Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
MMW - Fortschritte der Medizin
Erschienen in: MMW - Fortschritte der Medizin 11/2017

12.06.2017 | Erektile Dysfunktion | FORTBILDUNG . SEMINAR

Gendermedizin

Mann oder Frau: Ist das bei Diabetes relevant?

verfasst von: Dr. med. Jürgen Harreiter, MSc, Prof. Dr. med. Alexandra Kautzky-Willer

Erschienen in: MMW - Fortschritte der Medizin | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Es kristallisiert sich immer mehr heraus, dass es sich lohnt, beim Management von Diabetes mellitus geschlechtsspezifische Aspekte zu berücksichtigen. Dies gilt sowohl für Diagnostik und Therapie als auch in der Prävention und beim Umgang mit Komplikationen.
Literatur
1.
Kautzky-Willer, A., et al., [Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes]. Wien Klin Wochenschr, 2016. 128 Suppl 2: p. S151–8.CrossRefPubMed
2.
Kautzky-Willer, A., J. Harreiter, and G. Pacini, Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev, 2016. 37(3): p. 278–316.CrossRefPubMedPubMedCentral
3.
Kautzky-Willer, A., et al., Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. Gend Med, 2010. 7(6): p. 571–83.CrossRefPubMed
4.
Kautzky-Willer, A., et al., Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study. Cardiovasc Diabetol, 2013. 12: p. 78.CrossRefPubMedPubMedCentral
5.
6.
7.
Ng, M., et al., Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2014. 384(9945): p. 766–81.CrossRefPubMedPubMedCentral
8.
Robert Koch Institut. RKI- Faktenblatt zu DEGS1: Studie zur Gesundheit Erwachsener in Deutschland (2008– 2011). 2017 12.02.2017]; Available from: http://​www.​rki.​de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GBEDownloadsF/degs1/Diabetes_mellitus.pdf;jsessionid=22C578E5DEE4BABD513DBD334E8D8FEC.2_cid372?__blob=publicationFile.
9.
Kautzky-Willer, A., et al., Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS. BMC Public Health, 2012. 12: p. 392.CrossRefPubMedPubMedCentral
10.
DECODE Study Group, Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care, 2003. 26(1): p. 61–9.CrossRef
11.
Pischon, T., et al., General and abdominal adiposity and risk of death in Europe. N Engl J Med, 2008. 359(20): p. 2105–20.CrossRefPubMed
12.
13.
Anderwald, C., et al., Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab, 2011. 96(2): p. 515–24.CrossRefPubMed
14.
Glechner, A., et al., Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia, 2015. 58(2): p. 242–54.CrossRefPubMed
15.
Li, G., et al., Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol, 2014. 2(6): p. 474–80.CrossRefPubMed
16.
Feldman, H.A., et al., Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol, 1994. 151(1): p. 54–61.CrossRefPubMed
17.
Hackett, G., et al., Coronary Heart Disease, Diabetes, and Sexuality in Men. J Sex Med, 2016. 13(6): p. 887–904CrossRefPubMed
18.
Hunt, K., et al., A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trial. Lancet, 2014. 383(9924): p. 1211–21.CrossRef
19.
Crump, C., et al., Physical Fitness Among Swedish Military Conscripts and Long-Term Risk for Type 2 Diabetes Mellitus: A Cohort Study. Ann Intern Med, 2016. 164(9): p. 577–84.CrossRefPubMedPubMedCentral
20.
Bellamy, L., et al., Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet, 2009. 373(9677): p. 1773–9.CrossRefPubMed
21.
Harreiter, J., G. Dovjak, and A. Kautzky-Willer, Gestational diabetes mellitus and cardiovascular risk after pregnancy. Womens Health (Lond Engl), 2014. 10(1): p. 91–108.CrossRef
22.
Syngelaki, A., et al., Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. N Engl J Med, 2016. 374(5): p. 434–43.CrossRefPubMed
23.
24.
Poston, L., et al., Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol, 2015. 3(10): p. 767–77.CrossRefPubMed
25.
Simmons, D., et al., Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study. J Clin Endocrinol Metab, 2016: p. jc20163455.
26.
Chiswick, C., et al., Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol, 2015. 3(10): p. 778–86.CrossRefPubMedPubMedCentral
27.
Simmons, D., et al., Results From a European Multicenter Randomized Trial of Physical Activity and/or Healthy Eating to Reduce the Risk of Gestational Diabetes Mellitus: The DALI Lifestyle Pilot. Diabetes Care, 2015. 38(9): p. 1650–6.CrossRefPubMed
28.
Koivusalo, S.B., et al., Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial. Diabetes Care, 2015 [Epub ahead of print].
29.
Tobias, D.K., et al., Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care, 2011. 34(1): p. 223–9.CrossRefPubMed
30.
Aroda, V.R., et al., The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab, 2015. 100(4): p. 1646–53.CrossRefPubMedPubMedCentral
31.
Kautzky-Willer, A., et al., Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials. Diabetes Obes Metab, 2015. 17(6): p. 533–40.CrossRefPubMed
32.
Kautzky-Willer, A. and A. Handisurya, Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest, 2009. 39(8): p. 631–48.CrossRefPubMed
33.
Ridker, P.M., et al., A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med, 2005. 352(13): p. 1293–304.CrossRefPubMed
34.
Inzucchi, S.E., et al., Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2015. 38(1): p. 140–9.CrossRefPubMed
35.
Martin-Castillo, B., et al., Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle, 2010. 9(6): p. 1057–64.CrossRefPubMed
36.
Lee, M.S., et al., Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer, 2011. 11: p. 20.CrossRefPubMedPubMedCentral
37.
Sun, G.E., et al., Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus. Diabetes Obes Metab, 2014. 16(3): p. 276–83.CrossRefPubMed
38.
Habib, Z.A., et al., Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab, 2010. 95(2): p. 592–600.CrossRefPubMedPubMedCentral
39.
Wheeler, S., et al., Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy. Diabetologia, 2013. 56(9): p. 1934–43.CrossRefPubMed
40.
Zhang, Q., et al., Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database. Adv Ther, 2010. 27(4): p. 223–32.CrossRefPubMed
41.
Hirsch, I.B., et al., Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin. Endocr Pract, 2011. 17(5): p. 707–16.CrossRefPubMed
42.
Pencek, R., et al., Exenatide once weekly for the treatment of type 2 diabetes: effectiveness and tolerability in patient subpopulations. Int J Clin Pract, 2012. 66(11): p. 1021–32.CrossRefPubMedPubMedCentral
43.
Johnsson, K.M., et al., Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin. J Diabetes Complications, 2013. 27(5): p. 479–84.CrossRefPubMed
44.
McGill, J.B., et al., Effect of gender on treatment outcomes in type 2 diabetes mellitus. Diabetes Res Clin Pract, 2013. 102(3): p. 167–74.CrossRefPubMed
45.
McCollum, M., et al., Gender differences in diabetes mellitus and effects on self-care activity. Gend Med, 2005. 2(4): p. 246–54.CrossRefPubMed
46.
Klimek, P., et al., Quantification of diabetes comorbidity risks across life using nation-wide big claim data. PLoS Computer Biol, in press.
47.
Chiu, C.J. and L.A. Wray, Gender differences in functional limitations in adults living with type 2 diabetes: biobehavioral and psychosocial mediators. Ann Behav Med, 2011. 41(1): p. 71–82.CrossRefPubMed
48.
Lu, F.-P., W.-C. Chang, and S.-C. Wu, Geriatric conditions, rather than multimorbidity, as predictors of disability and mortality among octogenarians: A population-based cohort study. Geriatrics & Gerontology International, 2015.
49.
Ali, S., et al., The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med, 2006. 23(11): p. 1165–73.CrossRefPubMed
50.
51.
Collins, M.M., P. Corcoran, and I.J. Perry, Anxiety and depression symptoms in patients with diabetes. Diabet Med, 2009. 26(2): p. 153–61.CrossRefPubMed
52.
Carpenter, K.M., et al., Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health, 2000. 90(2): p. 251–7.CrossRefPubMedPubMedCentral
53.
Sullivan, M.D., et al., Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care, 2012. 35(8): p. 1708–15.CrossRefPubMedPubMedCentral
54.
Buchanan, T.A., A.H. Xiang, and K.A. Page, Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol, 2012. 8(11): p. 639–49.CrossRefPubMedPubMedCentral
55.
Yang, J., et al., Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol, 2006. 108(3 Pt 1): p. 644–50.CrossRefPubMed
56.
Rosen, R.C., et al., Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med, 2009. 6(5): p. 1414–22.CrossRefPubMedPubMedCentral
57.
Wing, R.R., et al., Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. Diabetes Care, 2013. 36(10): p. 2937–44.CrossRefPubMedPubMedCentral
58.
Mari, A., et al., Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med, 2008. 25(6): p. 671–7.CrossRefPubMed
59.
Wing, R.R., et al., Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med, 2010. 7(1 Pt 1): p. 156–65.CrossRefPubMed
60.
Rao, P.M., D.M. Kelly, and T.H. Jones, Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol, 2013. 9(8): p. 479–93.CrossRefPubMed
61.
de Hauteclocque, A., et al., The influence of sex on renal function decline in people with Type 2 diabetes. Diabet Med, 2014. 31(9): p. 1121–8.CrossRefPubMed
62.
Gomez-Marcos, M.A., et al., Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study. Cardiovasc Diabetol, 2015. 14(1): p. 132.CrossRefPubMedPubMedCentral
63.
Lin, C.H., et al., A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract, 2007. 75(3): p. 306–12.CrossRefPubMed
64.
Peek, M.E., Gender differences in diabetes-related lower extremity amputations. Clin Orthop Relat Res, 2011. 469(7): p. 1951–5.CrossRefPubMed
65.
Morbach, S., et al., Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care, 2012. 35(10): p. 2021–7.CrossRefPubMedPubMedCentral
66.
Peters, S.A., R.R. Huxley, and M. Woodward, Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia, 2014. 57(8): p. 1542–51.CrossRefPubMed
67.
Anand, S.S., et al., Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J, 2008. 29(7): p. 932–40.CrossRefPubMed
68.
Peters, S.A., R.R. Huxley, and M. Woodward, Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet, 2014. 383(9933): p. 1973–80.CrossRefPubMed
Metadaten
Titel
Gendermedizin
Mann oder Frau: Ist das bei Diabetes relevant?
verfasst von
Dr. med. Jürgen Harreiter, MSc
Prof. Dr. med. Alexandra Kautzky-Willer
Publikationsdatum
12.06.2017
Verlag
Springer Medizin
Erschienen in
MMW - Fortschritte der Medizin / Ausgabe 11/2017
Print ISSN: 1438-3276
Elektronische ISSN: 1613-3560
DOI
https://doi.org/10.1007/s15006-017-9793-0

Weitere Artikel der Ausgabe 11/2017

MMW - Fortschritte der Medizin 11/2017 Zur Ausgabe

AUS DER PRAXIS

Kann ich dem Sono-Gerät je wieder trauen?

AKTUELLE MEDIZIN . ONLINE-SPRECHSTUNDE

Die Interferon-Therapie ist eine Qual

FORTBILDUNG . KRITISCH GELESEN

Bei diesem Mädchen häuft sich Knochenmatrix an

AKTUELLE MEDIZIN . MAGAZIN

Abends keine Kohlenhydrate?

AKTUELLE MEDIZIN

Kaffee könnte vor Leberkrebs schützen

AKTUELLE MEDIZIN . REPORT

Saarbrücken, Freitag, 13. März 2015

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft. 

Zu den Praxisempfehlungen
Bildnachweise